Unit:
|
Xiuyu District People's Government of Putian City, Fujian Province
|
|
Project Area:
|
putian Xiuyu District
|
|
Industry:
|
Biological and New Pharmaceutical Industry
|
|
Type of Project:
|
New Project
|
|
Cooperation Mode:
|
Individual Proprietorship,Joint Venture,Collaborate
|
|
Nature of Project:
|
Permit
|
|
Working Progress in Prior Period:
|
Among them, the biopharmaceutical raw material production base project is expected to be jointly constructed by New Hope Fund and Haixi Pharmaceutical. The owner has organized two batches of partners to conduct site selection and on-site inspections, and
|
|
Total Investment:
|
500000 ten thousand RMB
|
|
Expected to Attract Investment:
|
500000 ten thousand RMB
|
|
Benefit Analysis:
|
none
|
|
Reason and Condition:
|
none
|
|
Others:
|
none
|
Biological & New Pharmaceutical Industry
In 2020, the added value of industrial enterprises above designated size rose by 0.3 percent year on year, and the output value of the industry exceeded RMB 60 billion. The technology of such protein drugs as recombinant human granulocyte-macrophage colony-stimulating factor and its market share took the lead in China. In addition, bio-pharmaceutical technologies such as an Escherichia coli-derived virus-like particle-based vaccine, a recombinant hepatitis E vaccine, and a recombinant human papillomavirus vaccine all held world leading positions.